Abshire T - Search Results

1

Briones M, Abshire T. Briones M, et al. Among authors: abshire t. Curr Opin Hematol. 2003 Sep;10(5):375-9. doi: 10.1097/00062752-200309000-00009. Curr Opin Hematol. 2003. PMID: 12913793 Review.

2

An approach to the diagnosis and treatment of bleeding disorders in infants.

Abshire TC. Abshire TC. Int J Hematol. 2002 Aug;76 Suppl 2:265-70. doi: 10.1007/BF03165128. Int J Hematol. 2002. PMID: 12430935 Review.

3

Dose optimization of recombinant factor VIIa for control of mild to moderate bleeds in inhibitor patients: Improved efficacy with higher dosing.

Abshire TC. Abshire TC. Semin Hematol. 2004 Jan;41(1 Suppl 1):3-7. doi: 10.1053/j.seminhematol.2003.11.002. Semin Hematol. 2004. PMID: 14872413 Review.

4

Safety update on recombinant factor VIIa in the treatment of congenital and acquired hemophilia.

Abshire T. Abshire T. Semin Hematol. 2008 Apr;45(2 Suppl 1):S3-6. doi: 10.1053/j.seminhematol.2008.03.006. Semin Hematol. 2008. PMID: 18544421 Review.

5

Determination of heparin-induced thrombocytopenia: a rapid flow cytometric assay for direct demonstration of antibody-mediated platelet activation.

Tomer A, Masalunga C, Abshire TC. Tomer A, et al. Among authors: abshire tc. Am J Hematol. 1999 May;61(1):53-61. doi: 10.1002/(sici)1096-8652(199905)61:1<53::aid-ajh10>3.0.co;2-f. Am J Hematol. 1999. PMID: 10331512 Free article.

6

A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.

Mitchell LG, Andrew M, Hanna K, Abshire T, Halton J, Anderson R, Cherrick I, Desai S, Mahoney D, McCuster P, Wu J, Dahl G, Chait P, de Veber G, Lee KJ, Mikulis D, Ginsberg J, Way C; Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase Group (PARKAA). Mitchell LG, et al. Among authors: abshire t. Cancer. 2003 Jan 15;97(2):508-16. doi: 10.1002/cncr.11042. Cancer. 2003. PMID: 12518376 Free article. Clinical Trial.

7

The new albumin-free recombinant factor VIII concentrates for treatment of hemophilia: do they represent an actual incremental improvement?

Josephson CD, Abshire T. Josephson CD, et al. Among authors: abshire t. Clin Adv Hematol Oncol. 2004 Jul;2(7):441-6. Clin Adv Hematol Oncol. 2004. PMID: 16163220

8

Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment.

Meeks SL, Abshire TC. Meeks SL, et al. Among authors: abshire tc. Haemophilia. 2008 Nov;14(6):1159-63. doi: 10.1111/j.1365-2516.2008.01832.x. Haemophilia. 2008. PMID: 19141155 Review.

9

Recent advances in the management of the child who has hemophilia.

Dunn AL, Abshire TC. Dunn AL, et al. Hematol Oncol Clin North Am. 2004 Dec;18(6):1249-76, viii. doi: 10.1016/j.hoc.2004.06.016. Hematol Oncol Clin North Am. 2004. PMID: 15511615 Review.

10

The use of Hepzyme in removing heparin from blood samples drawn from central venous access devices.

Forte K, Abshire T. Forte K, et al. Among authors: abshire t. J Pediatr Oncol Nurs. 2000 Jul;17(3):179-81. doi: 10.1053/jpon.2000.8066. J Pediatr Oncol Nurs. 2000. PMID: 10944866 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page